Ledger.Open graph →
SEC Form D · filed October 15, 2013

EXAGEN DIAGNOSTICS INC

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Albuquerque, NM
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Curt Labelle · Stamford, CTDirectorMichael J. Walsh · Del Mar, CADirectorSam Riccitelli · Encinitas, CADirectorBeto Pallares · Santa Fe, NMDirectorSteve Cooper · Rolling Hills Estates, CADirectorCarlos F. Barbas, Iii · Gaithersburg, MDDirectorHarry Fitzgibbons · London, United KingdomDirectorAnil K. Goyal · Atlanta, GADirectorFortunato R. Rocca · ALBUQUERQUE, NMExec · DirectorBeto Pallares · EL PASO, TXDirectorWendy Swedick · Albuquerque, NMExecThierry Dervieux · Albuquerque, NMExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗